{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T23:33:48Z","timestamp":1740180828285,"version":"3.37.3"},"reference-count":16,"publisher":"Consilium Medicum","issue":"8","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Terapevticheskii arkhiv"],"abstract":"<jats:p>Aim. \u0422o evaluate the modern view on the problem of chronic gastritis and the effectiveness of the drug ursodexic acid (UHC) Grinterol in the treatment of patients with chronic antral reflux-gastritis (biliar).\r\nMaterials and methods. The work provides modern ideas about chronic gastritis, the issues of etiology and pathogenesis are considered. Contemporary classifications and the attitude of the authors of the work to them are presented. Clinical studies were conducted in 50 patients with chronic antral reflux-gastritis biliary (32 women and 18 men) between the ages of 20 and 80 years (average age  50.3 to 8.0 years). The treatment uses the drug Grinterol in a daily dose of 12.5 mg\/kg of body weight for 4 weeks.\r\nResults. Among patients with chronic antral gastritis isolated patients with reflux-gastritis biliary, the pathogenetic factor of which is the damaging property of aggressive bile acids. The main treatment for such patients are drugs UHC (in this study (this study uses Grinterol at a daily dose of 12.5 mg\/kg of body weight); the duration of treatment is 4 years. The overall efficiency (according to endomorphological data) was 76%, according to clinical data  100%.\r\nDiscussion. Critical consideration of the classifications used and proposed for consideration indicates that the time has come for the adoption of a new classification with the allocation of reflux-gastritis biliary. Treatment of this form of antral gastritis is effective with UDHC drugs.\r\nConclusion. the selection of a form of antral reflux-gastritis biliar in a separate classification group is scientifically justified. The results suggest that for the treatment of patients with chronic biliary refluxdrugs of choice are drugs UDHC.<\/jats:p>","DOI":"10.26442\/00403660.2020.08.000693","type":"journal-article","created":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T05:42:50Z","timestamp":1599889370000},"page":"18-23","source":"Crossref","is-referenced-by-count":4,"title":["Chronic gastrite: modern state of the problem"],"prefix":"10.26442","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7723-7992","authenticated-orcid":false,"given":"O. N.","family":"Minushkin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6210-8955","authenticated-orcid":false,"given":"I. V.","family":"Zverkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0840-4590","authenticated-orcid":false,"given":"N. V.","family":"Lvova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3946-4983","authenticated-orcid":false,"given":"Yu. S.","family":"Skibina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9678-342X","authenticated-orcid":false,"given":"V. S.","family":"Inevatova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18344","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"key":"ref1","unstructured":"\u041c\u0438\u043d\u0443\u0448\u043a\u0438\u043d \u041e.\u041d. \u0425\u0440\u043e\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0433\u0430\u0441\u0442\u0440\u0438\u0442: \u043f\u0440\u0435\u0434\u0441\u0442\u0430\u0432\u043b\u0435\u043d\u0438\u044f, \u0434\u0438\u0430\u0433\u043d\u043e\u0441\u0442\u0438\u043a\u0430, \u043b\u0435\u0447\u0435\u0431\u043d\u044b\u0435 \u043f\u043e\u0434\u0445\u043e\u0434\u044b. \u041c\u0435\u0434. \u0441\u043e\u0432\u0435\u0442. 2007;1:71-6 [Minushkin ON. Chronic gastritis: representations, diagnosis, therapeutic approaches. Medical advice. 2007;1:71-6 (In Russ.)]."},{"key":"ref2","unstructured":"\u0411\u0443\u0440\u0434\u0438\u043d\u0430 \u0415.\u0413., \u041c\u0438\u043d\u0443\u0448\u043a\u0438\u043d \u041e.\u041d., \u0417\u0432\u0435\u0440\u043a\u043e\u0432 \u0418.\u0412. \u0420\u0430\u0446\u0438\u043e\u043d\u0430\u043b\u044c\u043d\u0430\u044f \u0444\u043e\u0440\u043c\u0430\u043a\u043e\u0442\u0435\u0440\u0430\u043f\u0438\u044f \u0445\u0440\u043e\u043d\u0438\u0447\u0435\u0441\u043a\u043e\u0433\u043e \u0433\u0430\u0441\u0442\u0440\u0438\u0442\u0430. \u042d\u0444\u0444\u0435\u043a\u0442\u0438\u0432\u043d\u0430\u044f \u0444\u0430\u0440\u043c\u0430\u043a\u043e\u0442\u0435\u0440\u0430\u043f\u0438\u044f. 2009;1:1-5 [Burdina EG, Minushkin ON, Zverkov IV. Rational formotherapy of chronic gastritis. Effective pharmacotherapy. 2009;1:1-5 (In Russ.)]."},{"key":"ref3","unstructured":"\u0413\u0430\u0441\u0442\u0440\u043e\u044d\u043d\u0442\u0435\u0440\u043e\u043b\u043e\u0433\u0438\u044f. \u041d\u0430\u0446\u0438\u043e\u043d\u0430\u043b\u044c\u043d\u043e\u0435 \u0440\u0443\u043a\u043e\u0432\u043e\u0434\u0441\u0442\u0432\u043e. \u041f\u043e\u0434 \u0440\u0435\u0434. \u0412.\u0422. \u0418\u0432\u0430\u0448\u043a\u0438\u043d\u0430, \u0422.\u041b. \u041b\u0430\u043f\u0438\u043d\u043e\u0439. \u041c., 2008 [Gastroenterology. National guideline. Ed. by VT Ivashkin, TL Lapina. Moscow, 2008 (In Russ.)]."},{"key":"ref4","unstructured":"\u042f\u043a\u043e\u0432\u0435\u043d\u043a\u043e \u042d.\u041f. \u0425\u0440\u043e\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0433\u0430\u0441\u0442\u0440\u0438\u0442, \u0434\u0438\u0430\u0433\u043d\u043e\u0441\u0442\u0438\u043a\u0430 \u0438 \u043b\u0435\u0447\u0435\u043d\u0438\u0435. \u0424\u0430\u0440\u043c\u0430\u0442\u0435\u043a\u0430. 2009;8:50-4 [Yakovenko EP. Chronic gastritis, diagnosis and treatment. Farmateka. 2009;8:50-4 (In Russ.)]."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-2050.2000.00063.x"},{"key":"ref6","unstructured":"Tanaka A, Tokunaga K, Takahashi S. The practical assessment of H. pylori eradication. Nihon Risho. 2013;71(8):1388-93."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309252"},{"key":"ref8","unstructured":"\u041c\u0430\u0435\u0432 \u0418.\u0412., \u0410\u043d\u0434\u0440\u0435\u0435\u0432 \u0414.\u041d., \u0421\u0430\u043c\u0441\u043e\u043d\u043e\u0432 \u0410.\u0410. \u0438 \u0434\u0440. \u042d\u0432\u043e\u043b\u044e\u0446\u0438\u044f \u043f\u0440\u0435\u0434\u0441\u0442\u0430\u0432\u043b\u0435\u043d\u0438\u0439 \u043e \u0434\u0435\u0444\u0438\u043d\u0438\u0446\u0438\u0438, \u043a\u043b\u0430\u0441\u0441\u0438\u0444\u0438\u043a\u0430\u0446\u0438\u0438, \u0434\u0438\u0430\u0433\u043d\u043e\u0441\u0442\u0438\u043a\u0435 \u0438 \u043b\u0435\u0447\u0435\u043d\u0438\u0438 \u0433\u0430\u0441\u0442\u0440\u0438\u0442\u0430, \u0430\u0441\u0441\u043e\u0446\u0438\u0438\u0440\u043e\u0432\u0430\u043d\u043d\u043e\u0433\u043e \u0441 \u0438\u043d\u0444\u0435\u043a\u0446\u0438\u0435\u0439 Helicobacter pylori. \u0424\u0430\u0440\u043c\u0430\u0442\u0435\u043a\u0430. 2016;6:24-33 [Maev IV, Andreev DN, Samsonov AA, et al. The evolution of ideas about the definition, classification, diagnosis and treatment of gastritis associated with Helicobacter pylori infection. Farmateka. 2016;6:24-33 (In Russ.)]."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1055\/a-0859-1883"},{"key":"ref10","unstructured":"\u041c\u0430\u0435\u0432 \u0418.\u0412., \u0421\u0430\u043c\u0441\u043e\u043d\u043e\u0432 \u0410.\u0410., \u0410\u043d\u0434\u0440\u0435\u0435\u0432 \u0414.\u041d. \u0420\u043e\u043b\u044c \u0438 \u043c\u0435\u0441\u0442\u043e \u0430\u043d\u0442\u0430\u0446\u0438\u0434\u043e\u0432 \u0432 \u0441\u043e\u0432\u0440\u0435\u043c\u0435\u043d\u043d\u044b\u0445 \u0430\u043b\u0433\u043e\u0440\u0438\u0442\u043c\u0430\u0445 \u0442\u0435\u0440\u0430\u043f\u0438\u0438 \u043a\u0438\u0441\u043b\u043e\u0442\u043e\u0437\u0430\u0432\u0438\u0441\u0438\u043c\u044b\u0445 \u0437\u0430\u0431\u043e\u043b\u0435\u0432\u0430\u043d\u0438\u0439. \u0424\u0430\u0440\u043c\u0430\u0442\u0435\u043a\u0430. 2013;2:66-72 [Maev IV, Samsonov AA, Andreev DN. The role and place of antacids in modern algorithms for the treatment of acid-dependent diseases. Farmateka. 2013;2:66-72 (In Russ.)]."},{"key":"ref11","unstructured":"\u041c\u0430\u0435\u0432 \u0418.\u0412., \u041a\u0443\u0447\u0435\u0440\u044f\u0432\u044b\u0439 \u042e.\u0410., \u0410\u043d\u0434\u0440\u0435\u0435\u0432 \u0414.\u041d., \u0411\u0430\u0440\u043a\u0430\u043b\u043e\u0432\u0430 \u0415.\u0412. \u042d\u0440\u0430\u0434\u0438\u043a\u0430\u0446\u0438\u043e\u043d\u043d\u0430\u044f \u0442\u0435\u0440\u0430\u043f\u0438\u044f \u0438\u043d\u0444\u0435\u043a\u0446\u0438\u0438 Helicobacter pylori: \u043e\u0431\u0437\u043e\u0440 \u043c\u0438\u0440\u043e\u0432\u044b\u0445 \u0442\u0435\u043d\u0434\u0435\u043d\u0446\u0438\u0439. \u0422\u0435\u0440\u0430\u043f\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0430\u0440\u0445\u0438\u0432. 2014;86(3):94-9 [Maev IV, Kucheryavyi YuA, Andreev DN, Barkalova EV. Eradication therapy for Helicobacter pylori infection: review of world trends. Therapeutic Archive. 2014;86(3):94-9 (In Russ.)]."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.17116\/terarkh20178985-12"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.17116\/terarkh201789284-90"},{"key":"ref14","unstructured":"\u041b\u043e\u0440\u0430\u043d\u0441\u043a\u0430\u044f \u0418.\u0414., \u0420\u0430\u043a\u0438\u0442\u0441\u043a\u0430\u044f \u041b.\u0413., \u041c\u0430\u043c\u0435\u0434\u043e\u0432\u0430 \u041b.\u0414. \u041f\u0440\u0438\u043c\u0435\u043d\u0435\u043d\u0438\u0435 \u043f\u0440\u0435\u043f\u0430\u0440\u0430\u0442\u0430 \u00ab\u041f\u0435\u043f\u0441\u0430\u043d \u0420\u00bb \u0432 \u043b\u0435\u0447\u0435\u043d\u0438\u0438 \u0433\u0430\u0441\u0442\u0440\u043e\u044d\u0437\u043e\u0444\u0430\u0433\u0435\u0430\u043b\u044c\u043d\u043e\u0439 \u0440\u0435\u0444\u043b\u044e\u043a\u0441\u043d\u043e\u0439 \u0431\u043e\u043b\u0435\u0437\u043d\u0438. \u042d\u043a\u0441\u043f\u0435\u0440\u0438\u043c\u0435\u043d\u0442\u0430\u043b\u044c\u043d\u0430\u044f \u0438 \u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0430\u044f \u0433\u0430\u0441\u0442\u0440\u043e\u044d\u043d\u0442\u0435\u0440\u043e\u043b\u043e\u0433\u0438\u044f. 2008;4:1-4 [Loranskaya ID, Rakitskaya LG, Mamedova LD. The use of the drug \u00abPepsan R\u00bb in the treatment of gastroesophageal reflux disease. Experimental and clinical gastroenterology. 2008;4:1-4 (In Russ.)]."},{"key":"ref15","unstructured":"\u041c\u0438\u043d\u0443\u0448\u043a\u0438\u043d \u041e.\u041d. \u0410\u043d\u0442\u0430\u0446\u0438\u0434\u043d\u044b\u0435 \u0441\u0440\u0435\u0434\u0441\u0442\u0432\u0430 \u0432 \u043b\u0435\u0447\u0435\u043d\u0438\u0438 \u0433\u0430\u0441\u0442\u0440\u043e\u044d\u0437\u043e\u0444\u0430\u0433\u0435\u0430\u043b\u044c\u043d\u043e\u0439 \u0440\u0435\u0444\u043b\u044e\u043a\u0441\u043d\u043e\u0439 \u0431\u043e\u043b\u0435\u0437\u043d\u0438. \u0424\u0430\u0440\u043c\u0430\u0442\u0435\u043a\u0430. 2007;6:1-3 [Minushkin ON. Antacids in the treatment of gastroesophageal reflux disease. Farmateka. 2007;6:1-3 (In Russ.)]."},{"key":"ref16","unstructured":"\u041f\u0440\u0435\u043f\u0430\u0440\u0430\u0442\u044b \u0443\u0440\u0441\u043e\u0434\u0435\u0437\u043e\u043a\u0441\u0438\u0445\u043e\u043b\u0435\u0432\u043e\u0439 \u043a\u0438\u0441\u043b\u043e\u0442\u044b \u0432 \u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u043f\u0440\u0430\u043a\u0442\u0438\u043a\u0435. \u041c\u0435\u0442\u043e\u0434\u0438\u0447\u0435\u0441\u043a\u043e\u0435 \u043f\u043e\u0441\u043e\u0431\u0438\u0435. \u0418\u0437\u0434. 2-\u0435. 2016 [Ursodeoxycholic acid preparations in clinical practice. Toolkit. Ed. 2nd. 2016 (In Russ.)]."}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"link":[{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/43536\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/43536\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T20:33:13Z","timestamp":1634157193000},"score":1,"resource":{"primary":{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/view\/43536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":16,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,9,3]]}},"URL":"https:\/\/doi.org\/10.26442\/00403660.2020.08.000693","relation":{},"ISSN":["2309-5342","0040-3660"],"issn-type":[{"type":"electronic","value":"2309-5342"},{"type":"print","value":"0040-3660"}],"subject":[],"published":{"date-parts":[[2020,9,3]]}}}